Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage
- PMID: 17266066
- PMCID: PMC1853385
- DOI: 10.1002/art.22471
Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage
Abstract
Objective: To quantify how visits and expenditures differ between insured patients with fibromyalgia syndrome (FMS) who visit complementary and alternative medicine (CAM) providers compared with patients with FMS who do not. Patients with FMS were also compared with an age- and sex-matched comparison group without FMS.
Methods: Calendar year 2002 claims data from 2 large insurers in Washington state were analyzed for provider type (CAM versus conventional), patient comorbid medical conditions, number of visits, and expenditures.
Results: Use of CAM by patients with FMS was 2.5 times higher than in the comparison group without FMS (56% versus 21%). Patients with FMS who used CAM had more health care visits than patients with FMS not using CAM (34 versus 23; P < 0.001); however, CAM users had similar expenditures to nonusers among patients with FMS ($4,638 versus $4,728; not significant), because expenditure per CAM visit is lower than expenditure per conventional visit. Patients with FMS who used CAM also had heavier overall disease burdens than those not using CAM.
Conclusion: With insurance coverage, a majority of patients with FMS will visit CAM providers. The sickest patients use more CAM, leading to an increased number of health care visits. However, CAM use is not associated with higher overall expenditures. Until a cure for FMS is found, CAM providers may offer an economic alternative for patients with FMS seeking symptomatic relief.
Figures
Similar articles
-
Comparison of health care expenditures among insured users and nonusers of complementary and alternative medicine in Washington State: a cost minimization analysis.J Altern Complement Med. 2010 Apr;16(4):411-7. doi: 10.1089/acm.2009.0261. J Altern Complement Med. 2010. PMID: 20423210 Free PMC article.
-
Insurance coverage and subsequent utilization of complementary and alternative medicine providers.Am J Manag Care. 2006 Jul;12(7):397-404. Am J Manag Care. 2006. PMID: 16834526 Free PMC article.
-
Complementary and alternative provider use by insured patients with diabetes in Washington State.J Altern Complement Med. 2006 Jan-Feb;12(1):71-7. doi: 10.1089/acm.2006.12.71. J Altern Complement Med. 2006. PMID: 16494571
-
The demographics and economics of complementary alternative medicine.Phys Med Rehabil Clin N Am. 2004 Nov;15(4):955-61, ix. doi: 10.1016/j.pmr.2004.04.003. Phys Med Rehabil Clin N Am. 2004. PMID: 15458762 Review.
-
Current trends in the integration and reimbursement of complementary and alternative medicine by managed care, insurance carriers, and hospital providers.Am J Health Promot. 1997 Nov-Dec;12(2):112-22. doi: 10.4278/0890-1171-12.2.112. Am J Health Promot. 1997. PMID: 10174663 Review.
Cited by
-
'If it's a medical issue I would have covered it by now': learning about fibromyalgia through the hidden curriculum: a qualitative study.BMC Med Educ. 2017 Sep 12;17(1):160. doi: 10.1186/s12909-017-0972-6. BMC Med Educ. 2017. PMID: 28899390 Free PMC article.
-
The Role of Complementary and Alternative Medicine Treatments in Fibromyalgia: a Comprehensive Review.Curr Rheumatol Rep. 2019 Mar 4;21(5):14. doi: 10.1007/s11926-019-0814-0. Curr Rheumatol Rep. 2019. PMID: 30830504 Review.
-
Preventive screening of women who use complementary and alternative medicine providers.J Womens Health (Larchmt). 2009 Aug;18(8):1133-43. doi: 10.1089/jwh.2008.1230. J Womens Health (Larchmt). 2009. PMID: 19630554 Free PMC article.
-
Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia.Rheumatol Int. 2009 Nov;30(1):1-21. doi: 10.1007/s00296-009-0977-5. Epub 2009 Aug 12. Rheumatol Int. 2009. PMID: 19672601
-
Intravenous micronutrient therapy (Myers' Cocktail) for fibromyalgia: a placebo-controlled pilot study.J Altern Complement Med. 2009 Mar;15(3):247-57. doi: 10.1089/acm.2008.0410. J Altern Complement Med. 2009. PMID: 19250003 Free PMC article. Clinical Trial.
References
-
- Pioro-Boisset M, Esdaile JM, Fitzcharles MA. Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res. 1996 Feb;9(1):13–17. - PubMed
-
- Crofford LJ, Appleton BE. Complementary and alternative therapies for fibromyalgia. Curr Rheumatol Rep. 2001 Apr;3(2):147–156. - PubMed
-
- Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol. 2003 Jun;30(6):1318–1325. - PubMed
-
- Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Wolfe F. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently. J Rheumatol. 2004 Aug;31(8):1621–1629. - PubMed
-
- Wolfe F, Anderson J, Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum. 1997 Sep;40(9):1560–1570. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous